Biotech company Aldea has raised $24m in a series B round featuring WuXi PharmaTech and Rusnano, which will support the treatment of patients with acute alcohol intoxication.

Mobile healthcare company Airstrip has raised $25m from investors including Qualcomm to expand into home health and foreign markets.

Shares in the Duke spin-out have reached a new all-time low.

Field tool Freedom4 can detect viruses and bacteria in samples.

Cell therapy company ViaCyte has entered into a rights agreement with Johnson & Johnson subsidiary Janssen following a $20m investment.

The Canon-backed medical imaging company is set to raise $26m from a share issue to subscribers including IDInvest Partners.

The Parkinson's disease drug developer has filed for an initial public offering the day after closing a $55m Alkermes-backed series C round.

Covagen, which is developing treatments for cancer and inflammatory diseases, has been acquired for an undisclosed sum, granting exits to Novartis and Seroba Kernel.